DAN ALEXANDER: Open Payments
NPI 1053385955 · BURGETTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 64 payments from 12 companies in 2025. Trend: 2023 $1,646 · 2024 $2,139 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $258 |
| Lilly USA, LLC | 13 | $250 |
| Novo Nordisk Inc | 7 | $149 |
| Exact Sciences Corporation | 7 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| PFIZER INC. | 2 | $48 |
| Abbott Laboratories | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
Products named: MOUNJARO, The Cologuard Plus Collection Kit, Kerendia, QULIPTA, JARDIANCE, VRAYLAR, Wegovy, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
